Document Detail

Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.
MedLine Citation:
PMID:  10688644     Owner:  NLM     Status:  MEDLINE    
c-myb is a frequent target of retroviral insertional mutagenesis in murine leukemia virus-induced myeloid leukemia. Induction of the leukemogenic phenotype is generally associated with inappropriate expression of this transcriptional regulator. Despite intensive investigations, the target genes of c-myb that are specifically involved in development of these myeloid lineage neoplasms are still unknown. In vitro assays have indicated that c-myc may be a target gene of c-Myb; however, regulation of the resident chromosomal gene has not yet been demonstrated. To address this question further, we analyzed the expression of c-myc in a myeloblastic cell line, M1, expressing a conditionally active c-Myb-estrogen receptor fusion protein (MybER). Activation of MybER both prevented the growth arrest induced by interleukin-6 (IL-6) and rapidly restored c-myc expression in nearly terminal differentiated cells that had been exposed to IL-6 for 3 days. Restoration occurred in the presence of a protein synthesis inhibitor but not after a transcriptional block, indicating that c-myc is a direct, transcriptionally regulated target of c-Myb. c-myc is a major target that transduces Myb's proliferative signal, as shown by the ability of a c-Myc-estrogen receptor fusion protein alone to also reverse growth arrest in this system. To investigate the possibility that this regulatory connection contributes to Myb's oncogenicity, we expressed a dominant negative Myb in the myeloid leukemic cell line RI-4-11. In this cell line, c-myb is activated by insertional mutagenesis and cannot be effectively down regulated by cytokine. Myb's ability to regulate c-myc's expression was also demonstrated in these cells, showing a mechanism through which the proto-oncogene c-myb can exert its oncogenic potential in myeloid lineage hematopoietic cells.
M Schmidt; V Nazarov; L Stevens; R Watson; L Wolff
Related Documents :
24236784 - Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhib...
14625684 - Cell cycle regulation by the b-myb transcription factor.
23895654 - The p53 mirna interactome and its potential role in the cancer clinic.
24374144 - P-stat3 and bcr/abl gene expression in chronic myeloid leukemia and their relation to i...
10645254 - Changes in equine endometrial oestrogen receptor alpha and progesterone receptor mrnas ...
11006154 - Expression of matrix metalloproteinases 2 and 9 in the mouse uterus during implantation...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular and cellular biology     Volume:  20     ISSN:  0270-7306     ISO Abbreviation:  Mol. Cell. Biol.     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-03-23     Completed Date:  2000-03-23     Revised Date:  2013-04-18    
Medline Journal Info:
Nlm Unique ID:  8109087     Medline TA:  Mol Cell Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1970-81     Citation Subset:  IM    
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Lineage / genetics
Cell Transformation, Neoplastic / genetics*
Gene Expression Regulation, Neoplastic
Genes, myb*
Genes, myc*
Leukemia, Myeloid / genetics*,  pathology
Tumor Cells, Cultured

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein...
Next Document:  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a hi...